TABLE 1.
Point prevalence, 12-month prevalence and 12-month incidence among the total population, and separately among girls and boys at age 11-14 years
| Total | Girls 746 (51.9%) | Boys 691 (48.1 %) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | N | % | CI | n | % | CI | n | % | CI |
| Point prev. 1 | 133 | 9.3 | 7.80 - 10.80 | 91 | 12.2 | 9.85 - 14.55 | 42 | 6.1 | 4.31 - 7.89 |
| Point prev. 2 | 113 | 7.9 | 6.50 - 9.30 | 80 | 10.8 | 8.57 - 13.03 | 33 | 4.8 | 3.20 - 6.40 |
| 12-month Prevalence | 42 | 2.9 | 2.03 - 3.77 | 33 | 4.5 | 3.01 - 5.99 | 9 | 1.3 | .45 - 2.15 |
| 12-month Incidence | 69 | 4.8 | 3.69 - 5.92 | 45 | 6.1 | 4.38 -7.82 | 24 | 3.5 | 2.13 - 4.87 |
1 Notes. CI = 95 % Confidence interval, Point prev.1 and 2 at assessment points 1 and 2.
Point prevalence (SMFQ ≥ 11) at first and second assessment point, 12-month prevalence (SMFQ ≥ 11) at assessment point 1 and 2), 12-month incidence rate (new cases with SMFQ ≥ 11 from assessment point 1 to assessment point 2) by gender